Stock Movers Capital One Sinks, Abercrombie & Fitch Tumbles, Medline Rises on Analyst Initiations
Jan 12, 2026
Natalia Knejevic, a Bloomberg reporter specializing in market analysis, shares insights on recent stock movements. She discusses Capital One's struggles following Trump's call for a 10% interest rate cap, which analysts warn could destabilize credit card earnings. Abercrombie & Fitch faces a tough outlook after disappointing holiday sales led to a 20% stock drop. In contrast, Medline sees a surge in share prices after positive analyst coverage following its IPO, highlighting its potential for growth and steady cash flow.
AI Snips
Chapters
Transcript
Episode notes
Card Rate Cap Threatens Bank Earnings
- Natalia Knejevic reports Capital One shares fell after Donald Trump urged a temporary 10% cap on credit-card interest rates.
- Wells Fargo's Mike Mayo warned such a cap could wipe out card earnings and cripple card lending economics.
Weak Holiday Sales Hit Retail Stocks
- Abercrombie & Fitch plunged about 20% after holiday sales disappointed and the company narrowed fourth-quarter sales guidance to ~5% growth.
- Natalia and Scarlet note consumers appear more cautious, hurting retail stocks.
Profitable IPO Draws Positive Analyst Views
- Medline (MDLN) gained as analysts began coverage after its large IPO and set a $47 average 12-month price target versus a $41.55 share price.
- Analysts see steady demand, margin expansion and predictable cash flow driving investor interest.